Day One Biopharmaceuticals, Inc. (DAWN)

10.67 +1.73 (+19.35%) USD  |  NASDAQ  |  Jan 12, 11:19
More

Day One Biopharmaceuticals Underperform Recommendations

Underperform Recommendations Chart

View Underperform Recommendations for DAWN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Underperform Recommendations Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Underperform Recommendations Range, Past 5 Years

View Underperform Recommendations Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Underperform Recommendations Benchmarks

View Underperform Recommendations Benchmarks
Start Trial
Mersana Therapeutics, Inc. Upgrade
Perspective Therapeutics, Inc. Upgrade
Electromed, Inc. Upgrade
InfuSystem Holdings, Inc. Upgrade
Xtant Medical Holdings, Inc. Upgrade